BIO operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2026	1,108,900,000
Mar 31, 2026	1,103,900,000
Dec 31, 2025	1,110,900,000
Sep 30, 2025	1,112,182,000
Jun 30, 2025	1,125,519,000
Mar 31, 2025	1,110,942,000
Dec 31, 2024	1,103,100,000
Sep 30, 2024	1,087,627,000
Jun 30, 2024	1,040,924,000
Mar 31, 2024	1,060,167,000
Dec 31, 2023	1,086,213,000
Sep 30, 2023	1,096,531,000
Jun 30, 2023	1,132,793,000
Mar 31, 2023	1,135,691,000
Dec 31, 2022	1,091,414,000
Sep 30, 2022	1,107,006,000
Jun 30, 2022	1,106,641,000
Mar 31, 2022	1,107,693,000
Dec 31, 2021	1,151,231,000
Sep 30, 2021	1,142,125,000
Jun 30, 2021	1,119,205,000
Mar 31, 2021	1,083,635,000
Dec 31, 2020	1,026,865,000
Sep 30, 2020	1,013,186,000
Jun 30, 2020	1,005,041,000
Mar 31, 2020	1,015,174,000
Dec 31, 2019	1,027,335,000
Sep 30, 2019	1,021,718,000
Jun 30, 2019	1,022,593,000
Mar 31, 2019	1,029,089,000
Dec 31, 2018	1,032,490,000
Sep 30, 2018	1,047,897,000
Jun 30, 2018	1,055,597,000
Mar 31, 2018	1,073,372,000
Dec 31, 2017	1,059,243,000
Sep 30, 2017	1,055,782,000
Jun 30, 2017	1,049,017,000
Mar 31, 2017	1,031,074,000
Dec 31, 2016	1,024,948,000
Sep 30, 2016	996,417,000
Jun 30, 2016	975,822,000
Mar 31, 2016	957,507,000
Dec 31, 2015	954,962,000
Sep 30, 2015	972,754,000
Jun 30, 2015	997,309,000
Mar 31, 2015	1,009,472,000
Dec 31, 2014	1,028,533,000
Sep 30, 2014	1,032,141,000
Jun 30, 2014	1,031,963,000
Mar 31, 2014	1,028,963,000
Dec 31, 2013	1,012,003,000
Sep 30, 2013	990,423,000
Jun 30, 2013	944,543,000
Mar 31, 2013	910,580,000
Dec 31, 2012	896,938,000
Sep 30, 2012	873,122,000
Jun 30, 2012	886,098,000
Mar 31, 2012	896,456,000
Dec 31, 2011	882,733,000
Sep 30, 2011	879,636,000
Jun 30, 2011	848,910,000
Mar 31, 2011	824,092,000
Dec 31, 2010	807,479,000
Sep 30, 2010	793,912,000
Jun 30, 2010	795,523,000
Mar 31, 2010	781,468,000
Dec 31, 2009	765,053,000
Sep 30, 2009	752,298,000
Jun 30, 2009	748,507,000
Mar 31, 2009	751,143,000
Dec 31, 2008	750,822,000
Sep 30, 2008	758,050,000
Jun 30, 2008	719,534,000
Mar 31, 2008	685,126,000
Dec 31, 2007	648,513,000
Sep 30, 2007	601,457,000
Jun 30, 2007	587,563,000
Mar 31, 2007	574,695,000
Dec 31, 2006	562,325,000
Sep 30, 2006	547,271,000
Jun 30, 2006	541,744,000
Mar 31, 2006	533,028,000
Dec 31, 2005	531,188,000
Sep 30, 2005	533,163,000
Jun 30, 2005	518,516,000
Mar 31, 2005	501,539,000
Dec 31, 2004	489,834,000
Sep 30, 2004	462,320,000
Jun 30, 2004	449,686,000
Mar 31, 2004	435,699,000
Dec 31, 2003	419,630,000
Sep 30, 2003	407,872,000
Jun 30, 2003	397,145,000
Mar 31, 2003	384,680,000
Dec 31, 2002	372,031,000
Sep 30, 2002	368,049,000
Jun 30, 2002	360,274,000
Mar 31, 2002	354,024,000
Dec 31, 2001	349,153,000
Sep 30, 2001	343,335,000